Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From LCA-Vision Inc.
Device/Diagnostics Quarterly Deal Statistics, Q1 2015
Device financing rose slightly to $934 million in Q1, while acquisition value was down to just over $4 billion. Diagnostics fundraising dropped significantly to $597 million; M&A activity was dominated by NGS and Roche's transaction with Foundation Medicine.
Deals In Depth: February 2015
AstraZeneca took on a large respiratory portfolio through a $700 million deal with Actavis; Pfizer improved biosimilar capabilities through its $17 billion takeover of Hospira. Follow-on public offerings dominated biopharma and device financing.
Deals Shaping The Medical Industry, March 2015
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, Pharmaceuticals, and Research/Analytical – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced February 2015.
Medical Device Deals Update, February 2015
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced January-February 2015.
Surgical Equipment & Devices
- Minimally or Less Invasive
- Other Names / Subsidiaries
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.